Contract facts
FederalNo full NAICS 561320 intel page yet. Browse NAICS intelligence
This Mod Is Issued to Reduce the Number of Regular Hours by 17 and Add Lin 2002 for Overtime PAY. No Additional Funding… is a federal award for 257-Network Contract Office 17 (36C257) held by Ghost Rx Inc. Estimated value $244K ($244K obligated). Current period of performance ends Feb 28, 2027. Place of performance: DALLAS TX.
This mod is issued to reduce the number of regular hours by 17 and add lin 2002 for overtime pay. no additional funding required. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Feb 28, 2027 (134 days remaining). Agencies typically plan 12–18 months ahead — at 4.4 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C25726N0096? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordGhost Rx Inc — $71.1M obligated across 221 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25726N0096?
36C25726N0096 (This mod is issued to reduce) is a 257-Network Contract Office 17 (36C257) award with a potential value of $244K, currently held by Ghost Rx Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C257-26-N-0096?
36C257-26-N-0096 is the dashed form of PIID 36C25726N0096 (This mod is issued to reduce), held by Ghost Rx Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25726N0096?
257-Network Contract Office 17 (36C257) awarded 36C25726N0096 to Ghost Rx Inc (potential $244K).
Who is the incumbent on 36C25726N0096?
Ghost Rx Inc is the incumbent with $71.1M across 221 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2027.
When does Ghost Rx Inc’s 36C25726N0096 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C25726N0096? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.